Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-14

Clinical Trial Update: Therapeutic Monitoring of Infliximab and Adalimumab

View source ↗

Summary

Clinical trial update regarding therapeutic monitoring of the biologic agents infliximab and adalimumab for inflammatory bowel diseases; current trial status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)
  • Infliximab (infliximab)

Snippet

Sponsor: IRCCS Burlo Garofolo | Conditions: Inflammatory Bowel Diseases | Status: UNKNOWN